🇺🇸 β-blockers in United States

β-blockers (β-blockers) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

β-blockers in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is β-blockers approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for β-blockers in United States?

Seiji Umemoto, M.D., Ph.D. is the originator. The local marketing authorisation holder may differ — check the official source linked above.